FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2023
Back to search
Official data from USPTO
YISHENGBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
10/03/2023
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
09/17/2021
Registration date
04/04/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/04/2023
Last transaction
04/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
16
Owner location
CN
Examiner
OJEYEMI, ASHLEY CHRISTINE
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "YISHENGBIO" in stylized green font.
Holders and representatives
Holders
Liaoning Yisheng Bio-Pharmaceutical Co., Ltd.
Representatives
Vincent O. Wagner
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugs for medical purpose for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; pharmaceutical preparations for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; vaccines; injectable medical solutions for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; medicines in the form of tablets for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; liquid medicine for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; nasal spray for medical purposes; ointment for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases; tumor suppressing agents; immunostimulants; medicines for human use for the prevention and treatment of rabies, malignant tumors, novel coronavirus infection and other infectious diseases
Publications
History of USPTO decisions and trademark events.
25 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/25/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
07/24/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2023
GPNX
NOTIFICATION PROCESSED BY IB
01/25/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2023
PUBO
PUBLISHED FOR OPPOSITION
01/17/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2022
RFNT
REFUSAL PROCESSED BY IB
07/20/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/25/2022
RFRR
REFUSAL PROCESSED BY MPU
06/25/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/23/2022
CNRT
NON-FINAL ACTION WRITTEN
06/22/2022
DOCK
ASSIGNED TO EXAMINER
06/22/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/25/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/24/2022
Continuous trademark protection
Get notified about every new filing that threatens YISHENGBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.